Victor Stone

Victor Stone M.D. (石井 喜英) is an accomplished leader in the biotechnology sector with a strong background in cell therapies and venture capital. Currently serving as President of 82VS Venture Studios and Head of Cell Therapies at Alloy Therapeutics, Inc., Victor also holds the position of General Partner at 82VS Fund. Prior roles include Consortia Director at Shonan Health Innovation Park and Co-Founder of Typewriter Therapeutics, Inc., along with serving as a Non-Executive Director at Axcelead Drug Discovery Partners, Inc. Victor's academic credentials include an MD in Medicine from Thomas Jefferson University and further business education from Harvard Business School.